Sagimet Biosciences (SGMT) Change in Cash (2022 - 2024)

Sagimet Biosciences' Change in Cash history runs 3 years deep, the most recent figure standing at -$80.8 million for Q2 2024.

• In Q2 2024, Change in Cash fell 1409.85% year-over-year to -$80.8 million; the TTM figure through Jun 2024 stood at $4.3 million (down 97.48% YoY), while the FY2025 annual figure was $1.6 million, up 114.43% from the prior year.
• Change in Cash for Q2 2024 stood at -$80.8 million, down from $101.6 million in the prior quarter.
• The five-year high for Change in Cash was $156.2 million in Q4 2022, with the low at -$99.8 million in Q4 2023.
• The 3-year median for Change in Cash is $9.2 million (2023), against an average of $22.1 million.
• The sharpest annual moves came in 2023 and 2024: Change in Cash jumped 3830.26% in 2023, then slumped 1409.85% in 2024.
• Sagimet Biosciences' Change in Cash stood at $156.2 million in 2022, then plunged by 163.9% to -$99.8 million in 2023, then advanced by 19.03% to -$80.8 million in 2024.
• Business Quant data shows SGMT's Change in Cash at -$80.8 million in Q2 2024, $101.6 million in Q1 2024, and -$99.8 million in Q4 2023.